摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(pyrimidin-5-yl)-1,3-thiazol | 1353560-27-6

中文名称
——
中文别名
——
英文名称
2-(pyrimidin-5-yl)-1,3-thiazol
英文别名
2-Pyrimidin-5-yl-1,3-thiazole
2-(pyrimidin-5-yl)-1,3-thiazol化学式
CAS
1353560-27-6
化学式
C7H5N3S
mdl
——
分子量
163.203
InChiKey
NPPXHDKUFPXODG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66.9
  • 氢给体数:
    0
  • 氢受体数:
    4

文献信息

  • [EN] PYRAZOLO [4, 3-D] PYRIMIDINES USEFUL AS KINASE INHIBITORS<br/>[FR] PYRAZOLO[4,3-D]PYRIMIDINES UTILES EN TANT QU'INHIBITEURS DE KINASES
    申请人:ORIGENIS GMBH
    公开号:WO2012143144A1
    公开(公告)日:2012-10-26
    The present invention relates to novel compounds of formula (I) that are capable of inhibiting one or more kinases, especially SYK (Spleen Tyrosine Kinase), LRRK2 (Leucine-rich repeat kinase 2) and/or MYLK (Myosin light chain kinase) or mutants thereof. The compounds find applications in the treatment of a variety of diseases. These diseases include autoimmune diseases, inflammatory diseases, bone diseases, metabolic diseases, neurological and neurodegenerative diseases, cancer, cardiovascular diseases, allergies, asthma, alzheimer's disease, parkinson's disease, skin disorders, eye diseases, infectious diseases and hormone-related diseases.
    本发明涉及一种能够抑制一个或多个激酶,特别是SYK(脾酪氨酸激酶)、LRRK2(富含亮酸重复的激酶2)和/或MYLK(肌球蛋白轻链激酶)或其突变体的化合物的新颖化合物(I)的公式。这些化合物在治疗各种疾病中发挥作用。这些疾病包括自身免疫疾病、炎症性疾病、骨疾病、代谢性疾病、神经和神经退行性疾病、癌症、心血管疾病、过敏、哮喘、阿尔茨海默病、帕森病、皮肤疾病、眼部疾病、传染病和与激素相关的疾病。
  • Heterocyclic compounds as pesticides
    申请人:BRETSCHNEIDER Thomas
    公开号:US20120165345A1
    公开(公告)日:2012-06-28
    The present application relates to novel heterocyclic compounds, to the use thereof for controlling animal pests, which include arthropods and especially insects, and to processes for preparing the novel compounds.
    本申请涉及新型杂环化合物,其用于控制动物害虫,包括节肢动物,特别是昆虫,并涉及制备这些新化合物的方法。
  • NEW COMPOUND 255
    申请人:Ghorpade Sandeep Raghunath
    公开号:US20100137303A1
    公开(公告)日:2010-06-03
    Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
    本文描述了化学式(I)的化合物及其药物可接受的盐。还描述了制备它们的过程,包含它们的制药组合物,以及它们作为药物用于治疗细菌感染的用途。
  • Heterocyclic Compounds as Pesticides
    申请人:Bayer CropScience AG
    公开号:US20140148471A1
    公开(公告)日:2014-05-29
    The present application relates to novel heterocyclic compounds, to the use thereof for controlling animal pests, which include arthropods and especially insects, and to processes for preparing the novel compounds.
    本申请涉及新型杂环化合物,其用于控制动物害虫,包括节肢动物,尤其是昆虫,并涉及制备这些新型化合物的过程。
  • TRIFLUOROMETHYLPYRI(MI)DINE CARBOXAMIDES
    申请人:Syngenta Participations AG
    公开号:EP1200413A1
    公开(公告)日:2002-05-02
查看更多